Literature DB >> 30007780

Late oral acetaminophen versus immediate surgical ligation in preterm infants with persistent large patent ductus arteriosus.

Sally Mashally1, Lynne E Nield2, Patrick J McNamara3, Fernando F Martins4, Afif El-Khuffash5, Amish Jain6, Dany E Weisz7.   

Abstract

OBJECTIVE: The study objective was to evaluate the association of oral acetaminophen therapy versus immediate surgical ligation with neonatal outcomes in infants with persistent patent ductus arteriosus.
METHODS: We performed a retrospective cohort study of preterm infants born 28+6 weeks or less gestational age with persistent large patent ductus arteriosus being considered for surgical ligation after unsuccessful medical therapy. Infants in epoch 1 (July 2009 to June 2012) were immediately referred for ligation, and infants in epoch 2 (July 2012 to June 2015) were treated with oral acetaminophen and referred for ligation in the absence of improvement. The primary outcome was a composite of death or chronic lung disease.
RESULTS: A total of 92 infants with median (interquartile range) gestational age 25.2 weeks (24.4-26.3) had persistent large patent ductus arteriosus (43 in epoch 1, 49 in epoch 2). Infants in epoch 2 had decreased surgical ligation (26 [53%] vs 31 [72%]; adjusted odds ratio [aOR], 0.32; 95% confidence interval [CI], 0.12-0.89) but increased chronic lung disease (36 [73%] vs 25 [58%]; aOR, 3.34; 95% CI, 1.05-10.58) and increased death/chronic lung disease of borderline significance (39 [80%] vs 29 [67%]; aOR, 3.09; 95% CI, 0.99-9.63). Infants in epoch 2 took longer to wean off of positive pressure ventilation (28.5 vs 24 days after enrollment; aOR, 0.52; 95% CI, 0.31-0.85).
CONCLUSIONS: Late oral acetaminophen therapy for infants with persistent patent ductus arteriosus is associated with reduced surgical ligation but increased chronic lung disease. In light of a lack of improvement in clinical outcomes, the individual contributory effects of acetaminophen, surgical ligation, and prolonged exposure to patent ductus arteriosus require further study to define the optimal approach.
Copyright © 2018 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ELGAN; PDA; acetaminophen; bronchopulmonary dysplasia; mortality

Mesh:

Substances:

Year:  2018        PMID: 30007780     DOI: 10.1016/j.jtcvs.2018.05.098

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  7 in total

Review 1.  Different approaches for patent ductus arteriosus in premature infants using acetaminophen.

Authors:  Aimann Surak; Amish Jain; Abbas Hyderi
Journal:  World J Pediatr       Date:  2022-03-06       Impact factor: 2.764

2.  [Timing of surgical ligation of patent ductus arteriosus in very low birth weight infants].

Authors:  Tai-Xiang Liu; Xiao-Lu Ma; Zheng Chen; Li-Ping Shi
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-05-15

Review 3.  Racing against time: leveraging preclinical models to understand pulmonary susceptibility to perinatal acetaminophen exposures.

Authors:  David J McCulley; Erik A Jensen; Jennifer M S Sucre; Sarah McKenna; Laura G Sherlock; Evgenia Dobrinskikh; Clyde J Wright
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2022-05-03       Impact factor: 6.011

4.  Is late treatment with acetaminophen safe and effective in avoiding surgical ligation among extremely preterm neonates with persistent patent ductus arteriosus?

Authors:  Sally Mashally; Rudaina Banihani; Bonny Jasani; Lynne E Nield; Fernando F Martins; Amish Jain; Dany E Weisz
Journal:  J Perinatol       Date:  2021-08-27       Impact factor: 2.521

Review 5.  Patent Ductus Arteriosus of the Preterm Infant.

Authors:  Shannon E G Hamrick; Hannes Sallmon; Allison T Rose; Diego Porras; Elaine L Shelton; Jeff Reese; Georg Hansmann
Journal:  Pediatrics       Date:  2020-11       Impact factor: 7.124

6.  Surgical ligation of patent ductus arteriosus in preterm neonates weighing less than 1500g: a 9-year single center experience.

Authors:  Jun Ho Lee; Hyun Ju Lee; Hyun-Kyung Park; Ja-Hye Ahn; Hee Sun Kim; Hyo Jun Jang; Sun Kyun Ro; Hyuck Kim
Journal:  J Cardiothorac Surg       Date:  2020-06-17       Impact factor: 1.637

7.  Selective Treatment of PDA in High-Risk VLBW Infants With Birth Weight ≤800 g or <27 Weeks and Short-Term Outcome: A Cohort Study.

Authors:  Thowfique Ibrahim; Abdul Alim Abdul Haium; Sarah Jane Tapawan; Rowena Dela Puerta; John C Allen; Suresh Chandran; Mei Chien Chua; Victor Samuel Rajadurai
Journal:  Front Pediatr       Date:  2021-01-28       Impact factor: 3.418

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.